These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6103066)

  • 1. On the effects of antirheumatic drugs on protein sulphydryl reactivity in human serum.
    Pickup ME; Dixon JS; Bird HA
    J Pharm Pharmacol; 1980 Apr; 32(4):301-2. PubMed ID: 6103066
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of antirheumatic drugs on protein sulphydryl reactivity of human serum.
    Hall NC; Gillan AH
    J Pharm Pharmacol; 1979 Oct; 31(10):676-80. PubMed ID: 41040
    [No Abstract]   [Full Text] [Related]  

  • 3. A study of the influence of various antirheumatic drug regimens on serum acute-phase proteins, plasma tryptophan, and erythrocyte sedimentation rate in rheumatoid arthritis.
    Aylward M; Maddock J; Wheeldon R; Parker RJ
    Rheumatol Rehabil; 1975 May; 14(2):101-14. PubMed ID: 238274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum sulphydryl levels in rheumatoid patients treated with alclofenac.
    Evans PH
    Curr Med Res Opin; 1975; 3(5):268-75. PubMed ID: 241596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum sulfhydryl levels in rheumatoid patients treated with gold thiomalate and penicillamine.
    Haataja M; Nissilä M; Ruutsalo HM
    Scand J Rheumatol; 1978; 7(4):212-4. PubMed ID: 104378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of anti-rheumatic drugs on human lymphocytes in vitro.
    Yoshino S; Ishiyama I
    Z Rheumatol; 1977; 36(1-2):28-35. PubMed ID: 402750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Action of sodium aurothiomalate on erythrocyte membrane.
    Campbell JM; Reglinski J; Smith WE; Porter D; Sturrock RD
    Ann Rheum Dis; 1992 Aug; 51(8):969-71. PubMed ID: 1417122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of possible mechanisms of action of the antirheumatic drug, alclofenac.
    Aylward M
    Curr Med Res Opin; 1975; 3(5):249-63. PubMed ID: 241594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic significance of laboratory results in rheumatic disease.
    Wright V; Dixon JS; Bird HA
    Semin Arthritis Rheum; 1985 Nov; 15(2 Suppl 1):8-13. PubMed ID: 2867602
    [No Abstract]   [Full Text] [Related]  

  • 10. The action of myocrisin on membrane bound sulphhydryl groups.
    McCrae F; Reglinski J; Smith WE; Brzeski M; Sturrock RD
    Clin Chim Acta; 1990 Dec; 195(1-2):41-5. PubMed ID: 1982710
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanism of action of the disease-modifying anti-arthritic thiol agents D-penicillamine and sodium aurothiomalate: restoration of cellular free thiols and sequestration of reactive aldehydes.
    Wood PL; Khan MA; Moskal JR
    Eur J Pharmacol; 2008 Feb; 580(1-2):48-54. PubMed ID: 18022616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative effectiveness of the basic drugs used in rheumatoid arthritis (long-term randomized study)].
    Tsvetkova ES
    Ter Arkh; 1985; 57(8):40-3. PubMed ID: 3934779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of second-line antirheumatic drugs on interleukin-8 mRNA synthesis and protein secretion in human endothelial cells.
    Deleuran B; Kristensen M; Paludan K; Zachariae C; Larsen CG; Zachariae E; Thestrup-Pedersen K
    Cytokine; 1992 Sep; 4(5):403-9. PubMed ID: 1358240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical parameters in the assessment of anti-inflammatory drugs--a review.
    Laurent MR; Panayi GS
    Agents Actions Suppl; 1980; 7():310-7. PubMed ID: 7018201
    [No Abstract]   [Full Text] [Related]  

  • 15. Disease-modifying drugs for progressive rheumatoid arthritis.
    Bunch TW; O'Duffy JD
    Mayo Clin Proc; 1980 Mar; 55(3):161-79. PubMed ID: 6766523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of anti-arthritic gold compounds on mycoplasma and leishmania.
    Berkoff CE; Actor P; Sutton BM; Walz DT; Klinikowski N
    Arzneimittelforschung; 1974 Dec; 24(12):1988-90. PubMed ID: 4217631
    [No Abstract]   [Full Text] [Related]  

  • 17. Is the mechanism of action during treatment of rheumatoid arthritis with penicillamine and gold thiomalate the same?
    Jellum E; Aaseth J; Munthe E
    Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):136-9. PubMed ID: 122761
    [No Abstract]   [Full Text] [Related]  

  • 18. Structural requirements for activity of certain 'specific' antirheumatic drugs: more than a simple thiol group?
    Drury PL; Rudge SR; Perrett D
    Br J Rheumatol; 1984 May; 23(2):100-6. PubMed ID: 6722409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1017 consecutive starts.
    Wolfe F; Hawley DJ; Cathey MA
    J Rheumatol; 1990 Aug; 17(8):994-1002. PubMed ID: 1976811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs for rheumatoid arthritis.
    Med Lett Drugs Ther; 1991 Jul; 33(848):65-70. PubMed ID: 1676134
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.